Paper of the Month
MYELODYSPLASTIC SYNDROMES: Genetics of MDS
With the use of advanced genomics this article provides a comprehensive registry of driver mutations recurrently found in MDS patients and correlates these with disease phenotype and prognosis.
IPSS-R MDS Risk Assessment Calculator
Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator
MDS Fact Sheet
NICE Guideline
Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.
